Harold L. Klawans
#112,657
Most Influential Person Now
Harold L. Klawans's AcademicInfluence.com Rankings
Harold L. Klawansmedical Degrees
Medical
#1548
World Rank
#1898
Historical Rank
Pharmacology
#133
World Rank
#169
Historical Rank
Download Badge
Medical
Harold L. Klawans's Degrees
- Doctorate Medicine University of Illinois College of Medicine
Why Is Harold L. Klawans Influential?
(Suggest an Edit or Addition)Harold L. Klawans's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The pharmacology of tardive dyskinesias. (1973) (462)
- Levodopa-induced psychosis: a kindling phenomenon. (1978) (310)
- Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. (1989) (274)
- Letter: Myoclonus, methysergide, and serotonin. (1974) (258)
- Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis (1982) (251)
- Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders. (1975) (225)
- Hypersexuality with antiparkinsonian therapy. (1989) (201)
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease (1994) (194)
- Tardive dyskinesia: review and update. (1980) (190)
- Effect of cholinergic and anticholinergic agents on tardive dyskinesia 1 (1974) (174)
- United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants (1991) (171)
- Hypertension and Risk of Stroke in an Elderly Population (1974) (167)
- Levodopa‐Induced dopamine receptor hypersensitivity (1977) (162)
- Oxidation reactions in Parkinson's disease. Discussion (1990) (150)
- Central cholinergic‐anticholinergic antagonism in Huntington's chorea (1972) (148)
- Chorea induced by oral contraceptives (1979) (147)
- The pharmacology of extrapyramidal movement disorders. (1972) (147)
- Gilles de la Tourette syndrome after long‐term chlorpromazine therapy (1978) (145)
- A pharmacologic analysis of Huntington's chorea. (1970) (143)
- High Speed Memory Scanning in Parkinsonism (1980) (139)
- Bupropion in Parkinson's disease (1984) (138)
- Individual manifestations of Parkinson's disease after ten or more years of levodopa (1986) (126)
- Pharmacology of hallucinations induced by long-term drug therapy. (1982) (123)
- An experimental model of tardive dyskinesia (2005) (115)
- Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. (1978) (111)
- Calcification of the basal ganglia (1979) (110)
- A pure parkinsonian syndrome following acute carbon monoxide intoxication. (1982) (109)
- Modification of postsynaptic dopaminergic sensitivity by female sex hormones. (1979) (102)
- Levodopa-induced myoclonus. (1975) (99)
- Hereditary neuropathies and spinocerebellar atrophies (1991) (98)
- Drug holiday and management of Parkinson disease (1980) (96)
- Use of L-dopa in the detection of presymptomatic Huntington's chorea. (1972) (95)
- Dream phenomena induced by chronic levodopa therapy (2005) (91)
- Sydenham chorea (1980) (88)
- Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias. (1972) (84)
- Teaching tape for the motor section of the unified Parkinson's disease rating scale (1995) (84)
- Treatment and prognosis of hemiballismus. (1976) (83)
- Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease (1990) (83)
- INTELLECTUAL FUNCTIONING OF PERSONS WITH IDIOPATHIC PARKINSONISM (1972) (82)
- Epidemiology of stroke in an elderly welfare population. (1974) (75)
- Dystonic foot response of Parkinsonism. (1980) (75)
- The pharmacology of choreatic movement disorders (1976) (75)
- The relative importance of dopamine and norepinephrine in mediating locomotor activity (1983) (73)
- Memory failure in Huntington's disease. (1987) (72)
- Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias1 (1974) (72)
- Chronic agonist therapy for Parkinson's disease (1985) (71)
- Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results. (1990) (70)
- The effect of d‐amphetamine on choreiform movement disorders (1974) (65)
- Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior. (1972) (64)
- Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia. (1971) (64)
- Hemiparkinsonism as a late complication of hemiatrophy (1981) (63)
- Synaptic plasticity in the rat striatum following chronic haloperidol treatment. (1992) (63)
- Dopamine binding following prolonged haloperidol pretreament (1978) (62)
- Blinded evaluation confirms long‐term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease (1992) (61)
- Psychiatric complications of levodopa therapy of Parkinson's disease. (1984) (61)
- The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. (1988) (60)
- Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias. (1975) (59)
- Transient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population (1973) (58)
- Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior. (1973) (57)
- Fluphenazine and multifocal tic disorders. (1984) (56)
- Meiges disease: a clinical form of facial convulsion, bilateral and medial. (1979) (56)
- Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour. (2009) (56)
- Psychiatric side effects during the treatment of Parkinson's disease. (1988) (55)
- L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism. (1969) (53)
- The effect of lithium on an animal model of tardive dyskinesia. (1977) (52)
- Observations on the efficacy of L-dopa in progressive supranuclear palsy. (1971) (51)
- Gilles de la Tourette on Tourette syndrome. (1982) (51)
- TOXIC EFFECTS OF AMANTADINE IN PATIENTS WITH RENAL FAILURE (1979) (50)
- Prolonged drug-induced Parkinsonism. (1973) (49)
- Pathophysiology of schizophrenia and the striatum. (1972) (49)
- Controlled‐release carbidopa/levodopa (CR4‐Sinemet) in Parkinson's disease patients with and without motor fluctuations (1988) (48)
- Striatal Extracts from Patients with Parkinson's Disease Promote Dopamine Neuron Growth in Mesencephalic Cultures (1993) (47)
- Amantadine and motor fluctuations in chronic Parkinson's disease. (1987) (47)
- L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia. (1990) (46)
- Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity (1980) (45)
- Hemiparkinsonism with hemiatrophy (1988) (44)
- Behavior disturbance in children with Tourette syndrome. (1982) (41)
- Parkinson's disease and motor fluctuations (1987) (41)
- Cholinergic mechanisms in Tourette syndrome (1982) (41)
- The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behavior. (1980) (40)
- Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration (1975) (39)
- On the role of dopamine in the pathophysiology of anorexia nervosa (2005) (38)
- Carbon monoxide-induced Parkinsonism. (1972) (38)
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agent (1980) (37)
- The Reversibility of “Permanent” Tardive Dyskinesia (1984) (36)
- Reversal of the glabellar reflex in Parkinsonism by L-dopa. (1969) (35)
- Primary writing tremor (1982) (35)
- Direct microdetermination of manganese in normal serum and cerebrospinal fluid by flameless atomic absorption spectrophotometry. (1976) (34)
- Agonist substitution in advanced Parkinson's disease (1989) (34)
- Levodopa during pregnancy. (1985) (34)
- Parkinsonism as a falling sickness. (1974) (34)
- The role of serotonin in the pathophysiology of myoclonic seizures associated with acute imipramine toxicity (1974) (34)
- Tourette-like symptoms following chronic neuroleptic therapy. (1982) (33)
- Serotonergically active agents in levodopa-induced psychiatric toxicity reactions. (1983) (33)
- Cerebrospinal fluid homovanillic acid in Huntington's chorea. (1971) (33)
- Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. (1989) (32)
- Tardive Dyskinesia: Pharmacology and Clinical Implications (1982) (32)
- A NEW ANIMAL MODEL FOR SCHIZOPHRENIA: BEHAVIORAL AND RECEPTOR BINDING STUDIES (1979) (31)
- The pharmacology of olivopontocerebellar atrophy. (1984) (31)
- Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. (1986) (31)
- Neurologic examination in an elderly population. (1971) (30)
- Effect of chlorphromazine on central nervous system concentrations of manganese, iron, and copper. (1977) (30)
- Levodopa and presymptomatic detection of Huntington's disease--eight-year follow-up. (1980) (29)
- The influence of caffeine on d-amphetamine- and apomorphine-induced stereotyped behavior. (1974) (29)
- Dystonia and tremor following exposure to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (1987) (29)
- Significance of genetic factors in Gilles de la Tourette syndrome: A review (1978) (29)
- Failure of vitamin B6 to reverse the l-dopa effect in patients on a dopa decarboxylase inhibitor (1971) (27)
- CLUSTER HEADACHE AND BRADYCARDIA (1976) (27)
- l-Dopa in Parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration) (1971) (27)
- Drug-induced extrapyramidal disorders - a neuropsychiatric interface. (1981) (26)
- Levodopa-Induced Psychosis (1978) (26)
- Complications of chronic levodopa therapy (1981) (26)
- Cerebrospinal Fluid from Patients with Parkinson's Disease Alters the Survival of Dopamine Neurons in Mesencephalic Culture (1994) (26)
- Observations on the dopaminergic nature of hyperthyroid chorea (2005) (25)
- Toward an understanding of the pathophysiology of Huntington's chorea. (1971) (25)
- Epidemiology and pathophysiology of tardive dyskinesias. (1988) (25)
- Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures (1991) (25)
- Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity (1990) (24)
- Textbook of clinical neuropharmacology (1981) (24)
- Meige disease (1982) (24)
- Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. (1989) (23)
- Drug holiday in the management of Parkinson disease. (1982) (23)
- The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. (1986) (22)
- Dopaminergic antagonism of L‐5‐hydroxytryptophan‐induced myoclonic jumping behavior (1979) (22)
- Amantadine toxicity in a patient with renal insufficiency. (1974) (22)
- Pergolide in Parkinson's disease. (1983) (22)
- Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. (1981) (22)
- Benign orgasmic cephalgia. (1974) (22)
- United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up. (1990) (22)
- Neuroleptic-induced tardiave dyskinesias in nonpsychotic patients. (1974) (21)
- Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat. (1991) (21)
- Chorea in childhood. (1993) (20)
- Dopamine receptor site sensitivity in hyperthyroid guinea pigs: A possible model of hyperthyroid chorea (2005) (20)
- The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviors (1987) (20)
- The pathophysiology of tardive dyskinesia. (1985) (20)
- An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation (1988) (20)
- Deanol in the treatment of levodopa‐induced dyskinesias (1975) (19)
- Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease (1973) (19)
- Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan. (2009) (19)
- Phenytoin and choreic movements. (1978) (18)
- Recurrence of childhood multiple tic in late adult life. (1985) (18)
- Neurologic manifestations of Paget's disease of the skull. (1971) (18)
- Pergolide mesylate (1985) (17)
- Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. (1988) (17)
- Observations on the use of methysergide in Huntington's chorea (1972) (17)
- Cyclizine-induced chorea Observations on the influence of cyclizine on dopamine-related movement disorders (1977) (16)
- Predicting Parkinson's disease. Discussion (1990) (16)
- Neurological sequelae of end stage renal disease (ESRD). (1977) (16)
- Biological aspects of anorexia nervosa. (1976) (16)
- Lingual‐Facial‐Buccal Movements in the Elderly. II. Pathogenesis and Relationship to Senile Chorea (1973) (16)
- Chapter 1: The Pharmacology of Schizophrenia (1976) (15)
- Compressive neuropathies in Tourette syndrome. (1982) (15)
- Reversal of tricyclic-overdosage-induced central anticholinergic syndrome by physostigmine. (1976) (15)
- Pergolide mesylate: four years experience in Parkinson's disease. (1987) (14)
- Cardiovascular and cerebrovascular disease in an elderly poor urban population. (1971) (14)
- Drug‐induced asterixis in Parkinson disease (1982) (14)
- Animal models of tardive dyskinesias. (1983) (13)
- 5-Hydroxytryptophan induced behavior in intact guinea pigs. (1973) (13)
- The pharmacology of parkinsonism (a review). (1968) (13)
- Behavioral Alterations and the Therapy of Parkinsonism (1982) (13)
- Drug-induced myoclonus. (1986) (13)
- CHOLINERGIC-MONOAMINERGIC INTERACTIONS WITHIN THE STRIATUM: IMPLICATIONS FOR CHOREIFORM DISORDERS (1978) (13)
- A clinical study of methysergide in Parkinsonism: evidence against a serotonergic mechanism. (1973) (13)
- Serotonin role in Huntington's chorea. (1972) (13)
- Convulsive disorders: mechanisms of epilepsy and anticonvulsant action. (1990) (12)
- Letter: Accumulation of amantadine hydrochloride in renal insufficiency. (1974) (12)
- Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs (1983) (12)
- Prolonged neuromuscular blockade with pancuronium bromide in a young healthy woman. (1974) (12)
- Clonazepam and dopamine-related stereotyped behavior. (1977) (12)
- Textbook of Clinical Neuropharmacology and Therapeutics (1992) (12)
- Depression and cognitive changes in Parkinson's disease: a review. (1987) (12)
- Diseases of the motor system (1991) (12)
- Handbook of clinical neurology. Vol. 35. Infections of the nervous system. Part III. (1978) (12)
- Selegiline HCl : selective MAO-type B inhibitor. Discussion (1990) (11)
- Neuroleptic-induced dopamine hyposensitivity. (1984) (11)
- Chapter 8: Pharmacology of Ballismus (1979) (11)
- Myoclonus and parkinsonism. (1986) (11)
- Animal models of tardive dyskinesia: their use in the search for new treatment methods. (1983) (10)
- Levodopa-induced dopaminergic hypersensitivity in the pathogenesis of psychiatric and neurologic disorders. (1979) (10)
- Regional Brain Manganese Levels in an Animal Model of Tardive Dyskinesia (1980) (10)
- Paradoxial response to dopaminergic agents in parkinsonism. (1978) (10)
- Dopamine receptor site sensitivity in hyperthyroid and hypothyroid guinea pigs. (1974) (10)
- Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin a or basic fibroblast growth factor in ventricular fluid (1991) (10)
- Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. (1987) (10)
- Observations on the mechanism of parkinsonian blepharospasm and its treatment with L-dopa. (1970) (10)
- Levodopa-free periods ("drug holidays") in the management of parkinsonism. (1983) (10)
- Clinical and experimental studies of phenytoin-induced hyperkinesias (2005) (10)
- The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy (1982) (10)
- Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning (1978) (9)
- Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy. (1977) (9)
- Models of human neurological diseases (1974) (9)
- Toscanini's Fumble and Other Tales of Clinical Neurology (1989) (8)
- A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. (1983) (8)
- The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity (1977) (8)
- Why Michael Couldn't Hit, and Other Tales of the Neurology of Sports (1996) (8)
- Primitive reflexes in parkinsonism. (1971) (8)
- Clinical Problems: Levodopa Therapy of Patients with Parkinsonism and Heart Disease (1972) (8)
- Pathophysiology and pharmacotherapy of tremor (1977) (8)
- Treatment of parkinsonism with L-dopa (study of 105 patients). (1969) (8)
- Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency. (1976) (8)
- The effect of dimethylaminoethanol (deanol) on amphetamine-induced stereotyped behavior (AISB). (1976) (8)
- II. The Pharmacology of Parkinsonism (1972) (7)
- Levodopa therapy of patients with Parkinsonism and heart disease. (1972) (7)
- Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. (1990) (7)
- Levodopa in the presymptomatic diagnosis of Huntington's chorea. (1972) (7)
- Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment (1975) (7)
- Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). (1988) (7)
- Animal Models of Tardive Dyskinesias (1983) (7)
- Recognition and diagnosis of tardive dyskinesia. (1985) (6)
- Controversies in animal models of tardive dyskinesia (1981) (6)
- Amine precursors in neurologic disorders and the psychoses. (1975) (6)
- Bromocriptine: decreased clinical effects at higher dosages. (1979) (6)
- Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. (1990) (6)
- RELATION BETWEEN HANDEDNESS AND SIDE OF ONSET OF PARKINSONISM (1972) (6)
- Trials of an Expert Witness (1991) (6)
- Metrizamide and its neurologic complications. (1987) (6)
- Pergolide mesylate: new therapy for Parkinson disease. (1982) (6)
- Altered hypothermic responsiveness to (+)‐amphetamine (1976) (6)
- Striatal membrane 3H-dopamine binding in an animal model of tardive dyskinesia. (1978) (6)
- Diseases of the extrapyramidal system. (1970) (5)
- A pharmacological model of the pathophysioloyg of schizophrenia. (1975) (5)
- Delayed traumatic syringomyelia. (1968) (5)
- Effect of vitamin B 6 on levodopa-induced changes in spinal fluid homovanillic acid. (1971) (5)
- Multi‐infarct PSP (1987) (5)
- The effect of thioridazine on haloperidol induced behavioral hypersensitivity. (1986) (5)
- Hensing, 1719: An Account of the First Chemical Examination of the Brain and the Discovery of Phosphorus Therein (1984) (5)
- L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. (1986) (5)
- THE DAILY FLUCTUATION OF STRIATAL DOPAMINE CONTENT AND d-AMPHETAMINE AND APOMORPHINE INDUCED STEREOTYPIC BEHAVIOR (1979) (5)
- Correlation between daily dosage of chlorpromazine and subsequent supersensitivity. (1980) (4)
- Relationship between handedness and side of onset of parkinsonism. (1972) (4)
- Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity. (1983) (4)
- [Induction of dreams by levodopa]. (1978) (4)
- Tardive Dyskinesia: Prevention and Treatment (1986) (4)
- Therapeutic approaches to neuroleptic-induced tardive dyskinesias. (1976) (4)
- L-dopa and the negative symptoms of Parkinsonism. (1969) (4)
- Pharmacology of dementia. (1986) (4)
- MYOCLONUS, METHYSERGIDE, AND SEROTONIN (1974) (4)
- Treatment of choreoathetotic movements in chronic liver disease with a dopamine-blocking agent. Pathophysiologic implications. (1971) (3)
- A screening procedure for stroke. (1972) (3)
- What to do when Sinemet fails: Part one. (1984) (3)
- Biochemical and Behavioral Studies of Neuroleptic-lnduced Dopamine Hypersensitivity (1980) (3)
- Recent advances in the biochemical pharmacology of extrapyramidal movement disorders. (1977) (3)
- Haloperidol-induced plasma prolactin release: Sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat (2004) (3)
- Observations on the range of efficacy of L-dopa. (1971) (3)
- The Medicine of History from Paracelsus to Freud (1982) (3)
- Effect of naloxone on dopamine uptake and release in vitro in the striatum. (1984) (3)
- Failure of increased brain gamma-aminobutyric acid levels to influence amphetamine-induced stereotyped behavior. (1975) (3)
- Possible dopamine agonist properties of quipazine maleate. (1983) (3)
- Newton's Madness: Further Tales of Clinical Neurology (1990) (3)
- Cerebral calcinosis with polycystic encephalopathy. An unusual case. (1972) (3)
- Involuntary movement disorders--each has a meaning all its own. (1979) (3)
- Why Michael Couldn't Hit: (1996) (3)
- Anticholinergic Syndrome by Physostigmine (1976) (2)
- Fetal-tissue transplantation for Parkinson's disease. (1993) (2)
- The Extrapyramidal System: A Review of Function (1983) (2)
- Trials of an expert witness : tales of clinical neurology and the law (1991) (2)
- The Use of Dopamine Agonists and Antagonists in Neurology (1984) (2)
- Gastric acidity and levodopa in Parkinsonism. (1973) (2)
- An antibody in the CSF of Parkinson's disease patients: summary of data and potential role as a diagnostic marker (1990) (2)
- The role of substance P in the nigrostriatal system. (1980) (2)
- Epidemiology of stroke in elderly persons. (1970) (2)
- The combined effect of quipazine and haloperidol on plasma prolactin release. (1983) (2)
- Defending the Cavewoman: And Other Tales of Evolutionary Neurology (2000) (2)
- Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy. (1979) (2)
- THE TIME COURSE OF HALOPERIDOL-INDUCED DOPAMINE RECEPTOR SITE SUPERSENSITIVITY IN GUINEA PIGS (1979) (2)
- The Interaction of Naloxone with Striatal Dopaminergic Mechanisms (1979) (2)
- Controlled‐release Sinemet (1987) (2)
- Reversal oftheglabellar reflex inParkinsonism byL-dopa (1969) (2)
- Amantadine in Huntington's chorea. (1972) (1)
- Drug holiday and management of Parkinson disease (1982) (1)
- The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. (1981) (1)
- L-Dopa, B6, and α-Methyldopa Hydrazine (1973) (1)
- Drs. Goetz and Klawans Reply (1981) (1)
- Dr. Munoz and Drs. Holinger and Klawans Reply (1977) (1)
- PSYCHIATRIC REACTION TO ERGOT DERIVATIVES (1979) (1)
- The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity (2005) (1)
- Binding of Amantadine to Red Blood Cells (1984) (1)
- Complications of chronic levodopa therapy (1981) (1)
- Morphine may not produce true catalepsy. (1983) (1)
- THE ROLE OF SCHEDULING IN AMPHETAMINE HYPERSENSITIVITY AND TOLERANCE (1979) (1)
- Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion. (1981) (1)
- Letter: Considerations in the drug treatment of drug-induced and other acute dyskinesias. (1974) (1)
- Temporary levodopa withdrawal. (1986) (1)
- A Striatal-Derived DA Neuron Growth Factor: Implication in Parkinson’s Disease (1990) (1)
- Parkinsonism: is your treatment appropriate? (1980) (1)
- Life, Death and In Between: Tales of Clinical Neurology (1992) (1)
- Movement Disorders Induced by Neuroleptic Drugs (1986) (1)
- Further observation on the possible relationship between migraine and serum ammonia levels (1976) (1)
- VII. L-Dopa-Induced Dyskinesias (1973) (1)
- Neurologic emergencies. (1986) (0)
- "Catecholamines" in the brain. (1970) (0)
- 2628 – THE DEVELOPMENT OF 3H-DOPAMINE BINDING SITES IN GUINEA PIG STRIATAL MEMBRANES (1978) (0)
- Evidence for the Existence of Two Striatal Dopamine Receptors (1979) (0)
- Prevalence of spontaneous lingual‐facial‐buccal dyskinesias (1983) (0)
- Bromocriptine and dopamine receptor hypersensitivity (1979) (0)
- Chlorpromazine vs. amphetamine. (1968) (0)
- Assessment and treatment of drug-induced tremor. (1980) (0)
- Title Page / Table of Contents / Acknowledgments (1973) (0)
- Clinical Neuropharmacology. Volume 2. (1978) (0)
- Sequential drug holiday in Parkinson's disease (1984) (0)
- I. Introduction: The Extrapyramidal System (1973) (0)
- Subject Index Vol 3, 1970 (1970) (0)
- The Biochemical Basis of Neuropharmacology (1971) (0)
- Reply from the Authors (1979) (0)
- Introduction: A second revolution (1990) (0)
- L-Dopa, B 6 , and alpha-methyldopa hydrazine. (1973) (0)
- Muscle stiffness and muscle pain. (1981) (0)
- Management of Psychiatric Symptoms in Parkinson’s Disease (1989) (0)
- Drug holidays in management of Parkinson disease (1982) (0)
- L-dopa for progressive supranuclear palsy. (1969) (0)
- The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor acitivity (2005) (0)
- NATURE OF DOPAMINE RECEPTORS IN THE STRIATUM AND NUCLEUS ACCUMBENS (1979) (0)
- L-Dopa andthenegative symptomsofParkinsonism (1969) (0)
- 2549 – THE ROLE OF DOPAMINERGIC MECHANISMS IN NALOXONE INDUCED INHIBITION OF APOMORPHINE STEREOTYPY (1978) (0)
- Chorea (1987) (0)
- VIII. Hepatolenticular Degeneration and Other Dystonias (1973) (0)
- Altered hypothermic responsivness to (+)-amphetamine. (1976) (0)
- Modified out patient drug holiday in the management of parkinsonism (1981) (0)
- Subject Index Vol. 35,1973 (1973) (0)
- The effect of bromocriptine (BCT) on the on-off phenomenon (2005) (0)
- Chapter 9: Iatrogenic Neurology Neurologic Complications of Nonheuropsychiatric Agents (1979) (0)
- III. The Pharmacology of Diseases Closely Related to Parkinsonism (1973) (0)
- Reply (1981) (0)
- Contents, Vol. 3, 1970 (1970) (0)
- Hemiparkinsonism and hemiatrophy (1988) (0)
- VI. Pharmacologic and Biochemical Considerations in Other Choreiform States (1972) (0)
- Medicine's Last Commandment. (1993) (0)
- Glabellar reflex in lower mammals. (1971) (0)
- Chapter 9: Iatrogenic Neurology (1979) (0)
- Contents Vol. 35,1973 (1973) (0)
- Letters to the editor (0)
- The Effect of Lithium on Haloperidol-lnduced Supersensitivity to D-Amphetamine and Apomorphine (1980) (0)
- V. The Pharmacology of Huntington’s Chorea (1973) (0)
- Chorea induced by oral contraceptives (1980) (0)
- Improbability and substantia nigra. (1968) (0)
- Diseases of the muscle (2018) (0)
- Bromocriptine (1979) (0)
- A forme fruste of the pterygium syndrome? (1975) (0)
- Case stories and the ethics of voice; the case: an eloquent region; when music is last to be lost -- a neurologist's perspective; overview: hearing and editing good stories. (1994) (0)
This paper list is powered by the following services:
